 plasma glucos concentr bezafibr patient niddm goal studi treatment bezafibr improv toler non-insulin-depend diabet niddm studi niddm patient concentr normal kidney liver function diet sulfonylurea drug patient withdrew constip random mo treatment patient standard mixed-test-m toler test mtt cal overnight fast plasma glucos insulin c-peptid metabolit nonesterifi fatti acid nefa triglycerid concentr interv serum lipid fructosamin concentr monthli interv glucos nefa triglycerid concentr second mtt bezafibr patient placebo group serum insulin c-peptid level postprandi concentr bezafibr patient mo mean serum triglycerid concentr mM total serum cholesterol concentr mM low-dens lipoprotein cholesterol concentr mM bezafibr patient chang serum lipid concentr placebo group treatment patient niddm bezafibr improv toler serum lipid profil bezafibr treatment use adjunct therapi patient niddm